Soliman and colleagues [73] reported that Luminal A patients with Ki-67 less than 15% displayed better overall survival than luminal B with Ki-67 higher than 15%; and Ki-67 may be considered a valuable biomarker in breast cancer Egyptian patients. This evidence concerns the gene MKI67 and breast cancer.